首页 | 本学科首页   官方微博 | 高级检索  
     

半抗原修饰的肿瘤疫苗治疗小鼠T淋巴细胞瘤效果观察
引用本文:黄明宜,高全立,马保根,买玲,宋永平. 半抗原修饰的肿瘤疫苗治疗小鼠T淋巴细胞瘤效果观察[J]. 郑州大学学报(医学版), 2002, 37(5): 619-621
作者姓名:黄明宜  高全立  马保根  买玲  宋永平
作者单位:1. 河南职工医学院临床部,郑州,450003
2. 河南省血液病研究所,河南省肿瘤医院血液科,郑州,450008
摘    要:目的:探讨用半抗原修饰的瘤苗治疗小儿T淋巴细胞瘤的方法。方法:将C57BL/6小鼠随机分为灭活RMA(小鼠T淋巴细胞瘤来源的细胞系)肿瘤细胞组,二硝基苯(DNP)修饰的灭活RMA肿瘤细胞组,RMA肿瘤细胞破碎物组,DNP修饰的RMA肿瘤细胞破碎物组和生理盐水对照组共5组(每组10只),于免疫接种后第10d用RMA肿瘤细胞再攻击实验小鼠,观察它们抵抗RMA肿瘤细胞再攻击的能力(主要观察出瘤时间,肿瘤生长速度和生存期)。结果:DNP修饰的灭活PMA肿瘤细胞可诱导小鼠产生抗肿瘤免疫保护力,主要表现为小鼠肿瘤生长速度减慢,生存期延长。而灭活RMA肿瘤细胞,RMA肿瘤细胞破碎物和DNP修饰的肿瘤组织破碎物不能诱导小鼠产生抗肿瘤免疫保护力。结论:半抗原修饰的瘤苗可作为有效的抗淋巴瘤瘤苗。

关 键 词:二硝基苯 肿瘤疫苗 淋巴瘤 T细胞
修稿时间:2002-01-03

Treatment of T lymphoma with hapten modified tumor vaccine
HUANG Mingyi ),GAO Quanli ),MA Baogen ),MAI Ling ),SONG Yongping ) )Clinical Department,Henan workers' Medical College,Zhengzhou )Henan Research Institute of Hemopathy,Zhengzhou. Treatment of T lymphoma with hapten modified tumor vaccine[J]. Journal of Zhengzhou University: Med Sci, 2002, 37(5): 619-621
Authors:HUANG Mingyi )  GAO Quanli )  MA Baogen )  MAI Ling )  SONG Yongping ) )Clinical Department  Henan workers' Medical College  Zhengzhou )Henan Research Institute of Hemopathy  Zhengzhou
Affiliation:HUANG Mingyi 1),GAO Quanli 2),MA Baogen 2),MAI Ling 2),SONG Yongping 2) 1)Clinical Department,Henan workers' Medical College,Zhengzhou 450003 2)Henan Research Institute of Hemopathy,Zhengzhou 450008
Abstract:Aim: To study the method for treating mouse T lymphoma with hapten modified tumor vaccine. Methods: The C57BL/6 mice were randomly allocated into 5 groups(10 mice in each group): inactivated RMA (cellinage of mouse T cell lymphoma) tumor cell, DNP modified inactivated RMA tumor cell,broken RMA tumor cell, DNP modified broken RMA tumor cell, and normal saline groups.On the 10th day after vaccination, they were re attacked with RMA tumor cell to induce the anti tumor immune reaction.The tumor occur time, tumor volume, and survival time were observed. Results: DNP modified inactivated RMA tumor cells could induce anti tumor immune reaction and the mice had a lower tumor growth speed and a longer survival time after re attacked with RMA;whereas the inactivated RMA tumor cells,RMA broken tumor cells and the DNP modified tumor cell broken matters could not. Conclusion: Hapten modified tumor vaccine may be an effective anti tumor vaccine.
Keywords:DNP  tumor vaccine  lymphoma  T cell
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号